DLA Piper represented Axsome Therapeutics in the transaction. Axsome Therapeutics, a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, announced...
Axsome Therapeutics’ Acquisition of Sunosi
ImmuneID’s $50 Million Series A Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised ImmuneID on the deal. ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and...